Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer

BACKGROUND: Nearly half of muscle-invasive bladder cancer patients succumb to their disease following cystectomy. Selecting candidates for adjuvant therapy is currently based on clinical parameters with limited predictive power. This study aimed to develop and validate genomic-based signatures that...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitra, Anirban P., Lam, Lucia L., Ghadessi, Mercedeh, Erho, Nicholas, Vergara, Ismael A., Alshalalfa, Mohammed, Buerki, Christine, Haddad, Zaid, Sierocinski, Thomas, Triche, Timothy J., Skinner, Eila C., Davicioni, Elai, Daneshmand, Siamak, Black, Peter C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241889/
https://www.ncbi.nlm.nih.gov/pubmed/25344601
http://dx.doi.org/10.1093/jnci/dju290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241889/
https://www.ncbi.nlm.nih.gov/pubmed/25344601
http://dx.doi.org/10.1093/jnci/dju290

Ejemplares similares